Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the Record History, and the previous 'Revision: v3.5.3' entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-05-15T05:52:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A minor interface/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the page’s release/versioning rather than any study-record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision v3.5.2 was added and revision v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision (v3.5.0) was added to the record history, and an older revision (v3.4.3) was removed. This is a metadata/version-history change rather than an update to trial content.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:29.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-12T00:30:41.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed in the Study Record History; this routine site-release change does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:13:27.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.